BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

In the clinic for Nov. 9, 2023

Nov. 9, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advancell, Aim, Allgenesis, Alterity, Amgen, Arthrosi, Astrazeneca, Bioxcel, Durect, Gilead, HCW, Immatics, Janssen, Lumos, Morphogenesis, Replimune, Takeda.
Read More

In the clinic for Nov. 7, 2023

Nov. 7, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Alkeus, Apellis, Astellas, Astrazeneca, Bayer, Belite, Bloomsbury, Boehringer, Cassava, Celldex, Equillium, Faron, Fluoguide, Gannex, Idorsia, Immutep, Inflarx, Innovent, Iveric, Karyopharm, Kodiak, Maat, Mannkind, Moleculin, Moonlake, Neurosense, Nido, Qilu, Regenxbio, Soleno, Sellas, Sunstone, Tonix, Toragen, Vera, Verastem.
Read More
Gloved hand holding COVID-19 vaccine vial, syringe
Immune

NIAID selects Tonix’s COVID-19 vaccine candidate TNX-1800 for inclusion in Project Nextgen trials

Nov. 3, 2023
The National Institute of Allergy and Infectious Diseases (NIAID) is set to conduct a phase I trial with Tonix Pharmaceuticals Holding Corp.’s TNX-1800 (recombinant horsepox virus, live vaccine), a vaccine candidate to protect against COVID-19.
Read More

Regulatory actions for Nov. 2, 2023

Nov. 2, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, DBV, Hibio, Merck & Co., Novartis, Novavax, Ocular.
Read More

Other news to note for Nov. 2, 2023

Nov. 2, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Bayer, Blue Water, Globestar, Jaguar, J&J, Locanabio, Kura, Mirati, Prelude, Protagonist, Quadri, Rani, Sangamo, Siren, Smi, Theriva, Tonix.
Read More

In the clinic for Nov. 2, 2023

Nov. 2, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antibe, Ashvattha, Cardiol, Clearside, Curocell, Curevac, Cymabay, Dare, Evaxion, Innovative Cellular, Kazia, Merck & Co., Monopar, Silence, Soterios, Springworks, Tonix.
Read More

In the clinic for Oct. 31, 2023

Oct. 31, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allyx, Aptose, Aqilion, Coya, Deciphera, Geovax, GSK, Junshi, Leo, Novartis, Novelmed, Reviva, University of Oxford, Volastra, Vyne.
Read More
Structural model of dengue virus.
Infection

2-Thiouridine shows activity against DENV and SARS-CoV-2 ssRNA+ viruses

Oct. 30, 2023
Researchers from Hokkaido University (Japan) and colleagues have identified 2-thiouridine (s2U) as a broad-spectrum antiviral ribonucleoside analogue, by phenotypic screening of a library of 753 nucleoside analogues for antiviral effects. s2U showed antiviral activity against several ssRNA+ viruses, including DENV, SARS-CoV-2 and its variants of concern.
Read More

In the clinic for Oct. 27, 2023

Oct. 27, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Ascendis, Bioage, Biocryst, Biogen, Biontech, Biovie, Catalym, Dermata, Edgewise, Eisai, IDP, Janssen, Maat, Nkgen, Ocean, Pfizer, Triumvira, Vaccinex, Virion.
Read More

In the clinic for Oct. 25, 2023

Oct. 25, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Allergan, Aurion, Aviceda, Axsome, Beckley, Psytech, Boehringer Ingelheim, Cymabay, Effector, F2G, Ferring, Genascence, Highfield, Iksuda, Immunomic, Ironwood, Janssen, Leo, Lisata, Maia, Meiragtx, Mereo, Mind Medicine, Moderna, Neurocentrx, Neurotherapia, Nimmune, Oxford, Oxular, Protara, Quoin, Recce, Shanghai Fosun, Shionogi, Sparrow, Therini, Transcode, Upstream, Viking.
Read More
Previous 1 2 … 25 26 27 28 29 30 31 32 33 … 552 553 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • Chengdu Mfs Pharma synthesizes new compounds for pain

    BioWorld Science
    Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing